Showing results (1-10 of 54) with videos related to
Sort By:
Pageof 6
The Journal of Allergy and Clinical Immunology. in Practice|October 2, 2025
Penny-Wise and Pound-Foolish: A Cost-Effectiveness Analysis of Unrealized Gains and Hidden Costs of 95165 ReimbursementMarcus Shaker, Weily Soong, Priya BansalDermatology and Therapy|June 24, 2023
Chronic Spontaneous Urticaria: How to Measure It and the Need to Define Treatment SuccessApril W Armstrong, Weily Soong, Jonathan A BernsteinRespiratory Medicine|June 15, 2016
Long-term safety of aclidinium bromide/formoterol fumarate fixed-dose combination: Results of a randomized 1-year trial in patients with COPDJames F Donohue, Weily Soong, Xiao Wu, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 10, 2021
Omalizumab response in patients with asthma by number and type of allergenWeily Soong, Bongin Yoo, Hooman Pazwash, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 28, 2023
Real-world severe asthma biologic administration and adherence differs by biologic: CHRONICLE study resultsDennis K Ledford, Weily Soong, Warner Carr, et al.The World Allergy Organization Journal|December 11, 2023
Disease burden and predictors associated with non-response to antihistamine-based therapy in chronic spontaneous urticariaWeily Soong, Dhaval Patil, Irina Pivneva, et al.Advances in Therapy|April 16, 2025
Incidence and Prevalence of Chronic Spontaneous Urticaria Among Adult and Pediatric Populations in the United StatesYvonne Geissbühler, Maria M Balp, Aine McConnon, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 24, 2025
Effect of tralokinumab on moderate-to-severe atopic dermatitis in patients with atopic comorbiditiesAmy S Paller, Weily Soong, Mark Boguniewicz, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 17, 2022
Patient-oriented measures for phase 3 studies of tralokinumab for the treatment of atopic dermatitis (ECZTRA 1, 2, and 3)Eric L Simpson, Andreas Wollenberg, Weily Soong, et al.Journal of Asthma and Allergy|July 2, 2021
Health-Related Quality of Life and Productivity Among US Patients with Severe AsthmaWeily Soong, Bradley E Chipps, Sean O'Quinn, et al.Pageof 6